ライフサイエンスコーパス: renal plasma flow

1 ld standard for the measurement of effective renal plasma flow.

2 ld standard for the measurement of effective renal plasma flow.

3 ld standard for the measurement of effective renal plasma flow.

4 lomerular hyperfiltration and an increase in renal plasma flow.

5 61) without significant changes to effective renal plasma flow.

6 AH), is used clinically to measure effective renal plasma flow.

7 d that has historically been used to measure renal plasma flow.

8 Renal plasma flow (4.83+/-0.65 versus 2.37+/-0.62 ml/min

9 anied by declines in plasma NO and effective renal plasma flow and an increase in renal vascular resi

10 ng patients with SCD have elevated effective renal plasma flow and glomerular filtration rates, which

11 Renal plasma flow and plasma aldosterone were measured b

12 Renal plasma flow and plasma renin activity were measure

13 h chronic heart failure, serelaxin increased renal plasma flow and reduced the increase in filtration

14 Glomerular filtration, renal plasma flow, and clearance of the stable metabolit

15 ession, greater body mass index, lower basal renal plasma flow, and higher diastolic blood pressure t

16 s associated with lower GFR, lower effective renal plasma flow, and higher filtration fraction, even

17 Functional renal reserve, change in renal plasma flow, and percentage change in nitrate and

18 rate; GFR) and paraaminohippurate (effective renal plasma flow) clearances were measured in individua

19 lin (GFR) and para-aminohippurate (effective renal plasma flow) clearances, tubular sodium handling,

20 tracer with a capacity to measure effective renal plasma flow comparable to that of the clinical gol

21 8 +/- 6% greater GFR, and a 61 +/- 7% higher renal plasma flow, compared with lean dogs.

22 still substantial and sustained increases in renal plasma flow, cortical blood flow (20 +/- 4% increa

23 Renal plasma flow decreased similarly with Ang II infusi

24 partmental analysis for estimating effective renal plasma flow (ERPF in units of milliliters per minu

25 nstrumented rats increases GFR and effective renal plasma flow (ERPF) and decreases effective renal v

26 r recombinant human RLX 2 (rhRLX), effective renal plasma flow (ERPF) and glomerular filtration rate

27 ronic inhibition of NO synthase on effective renal plasma flow (ERPF) and glomerular filtration rate

28 n 3 d) that includes estimation of effective renal plasma flow (ERPF) from a single plasma sample in

29 dy, we retrospectively review 1626 effective renal plasma flow (ERPF) measurements in 197 patients wi

30 Effective renal plasma flow (ERPF) response to angiotensin II (Ang

31 n cortical blood flow (34 +/- 12% increase), renal plasma flow, GFR, and sodium excretion; however, t

32 iltration rate (I-iothalamate) and effective renal plasma flow (I-hippuran) measured 4 months before

33 Fenoldopam significantly increased renal plasma flow in a dose-dependent manner compared wi

34 n was used to independently assess effective renal plasma flow in each subject.

35 ficant changes in mean arterial pressure and renal plasma flow in either C or D rats but reduced glom

36 renin inhibition led to a larger increase in renal plasma flow in healthy human volunteers studied on

37 perfiltrating and showed the largest rise in renal plasma flow in response to irbesartan, whereas ren

38 Renal plasma flow increased by 29% with serelaxin and 14

39 Effective renal plasma flow increased in both groups after surgery

40 Renal plasma flow increased modestly between baseline an

41 llagen I in UUO-treated kidneys and enhanced renal plasma flow measured by Technetium-99m mercaptoace

42 on GFR (measured by iothalamate clearance), renal plasma flow (measured by para-amino hippurate clea

43 glomerular filtration rate (GFR), effective renal plasma flow, natriuresis, and diuresis.

44 creased plasma renin activity (P < 0.01) and renal plasma flow (P < 0.01); the latter effect plateaue

45 Renal plasma flow (para-aminohippurate clearance) and gl

46 In the second part of the study, renal plasma flow (para-aminohippurate clearance) and gl

47 PUA, GFR (inulin), effective renal plasma flow (para-aminohippurate), BP, and hemodyn

48 difference between serelaxin and placebo on renal plasma flow (para-aminohippuric acid clearance) an

49 hanges from baseline mean arterial pressure, renal plasma flow, plasma renin activity, aldosterone, u

50 Renal plasma flow, prevalence of acute kidney injury, in

51 ced the glomerular filtration rate (GFR) and renal plasma flow rate in diabetic rats, despite variabl

52 Arterial pressure, GFR, and renal plasma flow remained constant, but CsA restored th

53 -aminohippurate were used to measure GFR and renal plasma flow, respectively.

54 asma flow in response to irbesartan, whereas renal plasma flow rose less and GFR fell in patients wit

55 mide on glomerular filtration rate (GFR) and renal plasma flow (RPF) in heart failure patients are co

56 intrarenal renin activity, we have examined renal plasma flow (RPF) responses in a standardized prot

57 In all three groups, baseline renal plasma flow (RPF) was positively correlated with t

58 GFR and renal plasma flow (RPF) were measured as the clearance o

59 easured glomerular filtration rate (GFR) and renal plasma flow (RPF), and analysed renal structural i

60 Glomerular filtration rate (GFR), renal plasma flow (RPF), and filtration fraction (FF) (a

61 ong the three centers, but systolic BP, GFR, renal plasma flow (RPF), and filtration fraction were lo

62 Bilateral GFR, renal plasma flow (RPF), and para-aminohippurate (PAH) e

63 Bilateral GFR, renal plasma flow (RPF), and para-aminohippurate extract

64 mable from glomerular filtration rate (GFR), renal plasma flow (RPF), blood pressure, hematocrit, and

65 s (T1D) and relate the ratio to albuminuria, renal plasma flow (RPF), fat mass, and insulin sensitivi

66 s showed parallel increases in single-kidney renal plasma flow (RPF), renocortical volume, and glomer

67 The glomerular filtration rate, renal plasma flow, urinary albumin excretion, and blood

68 There were no differences in GFR, effective renal plasma flow, urine output, or sodium excretion for

69 y [GC]/mass spectrometry [MS] analysis), and renal plasma flow was determined with paraaminohippurate

70 Irrespective of gender, renal plasma flow was increased by 47% compared with bas

71 Renal plasma flow was measured by para-aminohippurate cl

72 sured with infusion of [6-(2)H2]glucose, and renal plasma flow was measured by para-aminohippurate cl

73 Renal plasma flow was measured by using paraaminohippura

74 In male MRL-lpr/lpr mice, renal plasma flow was significantly reduced in the 5lo-/

75 In contrast, corresponding renal plasma flow was the same in the two groups, such t

76 Renal plasma flow was unchanged at 293 +/- 124 ml/min/1.

77 Glomerular filtration rate and renal plasma flow were measured with iothalamate and par